JP2007506664A5 - - Google Patents

Download PDF

Info

Publication number
JP2007506664A5
JP2007506664A5 JP2006515980A JP2006515980A JP2007506664A5 JP 2007506664 A5 JP2007506664 A5 JP 2007506664A5 JP 2006515980 A JP2006515980 A JP 2006515980A JP 2006515980 A JP2006515980 A JP 2006515980A JP 2007506664 A5 JP2007506664 A5 JP 2007506664A5
Authority
JP
Japan
Prior art keywords
formula
compound
alkyl
optionally
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006515980A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007506664A (ja
Filing date
Publication date
Priority claimed from GBGB0314488.8A external-priority patent/GB0314488D0/en
Application filed filed Critical
Publication of JP2007506664A publication Critical patent/JP2007506664A/ja
Publication of JP2007506664A5 publication Critical patent/JP2007506664A5/ja
Pending legal-status Critical Current

Links

JP2006515980A 2003-06-20 2004-06-16 マトリックスメタロプロテイナーゼの阻害剤 Pending JP2007506664A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0314488.8A GB0314488D0 (en) 2003-06-20 2003-06-20 Therapeutically useful compounds
PCT/EP2004/006553 WO2004113279A1 (en) 2003-06-20 2004-06-16 Inhibitors of matrix metalloproteinase

Publications (2)

Publication Number Publication Date
JP2007506664A JP2007506664A (ja) 2007-03-22
JP2007506664A5 true JP2007506664A5 (enExample) 2007-07-26

Family

ID=27637076

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006515980A Pending JP2007506664A (ja) 2003-06-20 2004-06-16 マトリックスメタロプロテイナーゼの阻害剤

Country Status (5)

Country Link
US (2) US7375248B2 (enExample)
EP (1) EP1636174A1 (enExample)
JP (1) JP2007506664A (enExample)
GB (1) GB0314488D0 (enExample)
WO (1) WO2004113279A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0321538D0 (en) * 2003-09-13 2003-10-15 Glaxo Group Ltd Therapeutically useful compounds
KR101274309B1 (ko) 2005-02-22 2013-06-13 랜박시 래보러터리스 리미티드 천식 및 기타 질병의 치료를 위한 기질 메탈로프로테나제저해제로서 5-페닐-펜탄산 유도체
WO2008023336A2 (en) 2006-08-22 2008-02-28 Ranbaxy Laboratories Limited Matrix metalloproteinase inhibitors
US8389500B2 (en) 2008-10-30 2013-03-05 Gilead Sciences, Inc. Fused heterocyclic compounds as ion channel modulators
AU2010339508B2 (en) 2009-12-31 2016-02-04 Innocrin Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
WO2012015723A1 (en) 2010-07-26 2012-02-02 Bristol-Myers Squibb Company Sulfonamide compounds useful as cyp17 inhibitors
PH12013500198A1 (en) 2010-07-30 2013-03-11 Ranbaxy Laboratories Ltd Matrix metalloproteinase inhibitors
CA2812319A1 (en) 2010-09-24 2012-03-29 Ranbaxy Laboratories Limited Matrix metalloproteinase inhibitors
MX2013003362A (es) 2010-09-24 2013-06-05 Ranbaxy Lab Ltd Inhibidores de metaloproteinasa de matriz.
EP2926808A1 (en) 2012-11-28 2015-10-07 Administración General De La Communidad Autónoma De Euskadi Use of metalloprotease inhibitors for the treatment of polycystic liver diseases

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51139626A (en) 1975-05-29 1976-12-02 Sumitomo Chem Co Ltd A herbicide and a process for its preparation
AT368358B (de) * 1977-12-24 1982-10-11 Fisons Ltd Schaedlingsbekaempfungs- und pflanzenwachstumsregulierungsmittel
US5852192A (en) * 1992-03-11 1998-12-22 Dr. Karl Thomae Gmbh Cyclic urea derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
US5863949A (en) 1995-03-08 1999-01-26 Pfizer Inc Arylsulfonylamino hydroxamic acid derivatives
US5710171A (en) * 1995-05-24 1998-01-20 Merck & Co., Inc. Bisphenyl inhibitors of farnesyl-protein transferase
EP0795550B1 (en) * 1996-03-11 2002-06-05 Sankyo Company Limited Aniline derivatives having herbicidal activity their preparation and their use
EE03965B1 (et) * 1996-05-17 2003-02-17 Warner-Lambert Company Maatriksi metalloproteinaasi bifenüülsulfoonamiidinhibiitorid
WO1998009940A1 (en) * 1996-09-04 1998-03-12 Warner-Lambert Company Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases
GB9801690D0 (en) * 1998-01-27 1998-03-25 Pfizer Ltd Therapeutic agents
JPH11236369A (ja) * 1998-02-23 1999-08-31 Kotobuki Seiyaku Kk スルホンアミド誘導体及びその製造法並びにこれを含有する医薬組成物
AU757680B2 (en) * 1999-07-01 2003-02-27 Taisho Pharmaceutical Co., Ltd. Aminobenzoic acid derivatives
US6451832B2 (en) * 1999-12-23 2002-09-17 Boehringer Ingelheim Pharma Kg Benzimidazoles with antithrombotic activity
US6897237B2 (en) * 2000-04-28 2005-05-24 Shionogi & Co. Ltd. MMP-12 inhibitors
JP2002205986A (ja) * 2000-11-08 2002-07-23 Takeda Chem Ind Ltd ピリミジン誘導体およびそれを含有する除草剤
JP2002193800A (ja) 2000-12-22 2002-07-10 Taisho Pharmaceut Co Ltd Ｖｅｇｆ受容体拮抗剤
CA2490819A1 (en) 2001-04-13 2002-10-24 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as anti-inflammatory agents
GB0124928D0 (en) * 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
JP4219810B2 (ja) 2001-10-26 2009-02-04 塩野義製薬株式会社 Ｍｍｐ阻害作用を有するスルホンアミド誘導体

Similar Documents

Publication Publication Date Title
JP2006526590A5 (enExample)
JP2006507265A5 (enExample)
JP2009502743A5 (enExample)
JP2006526031A5 (enExample)
JP2007523139A5 (enExample)
JP2007510619A5 (enExample)
JP2004536811A5 (enExample)
JP2009538336A5 (enExample)
JP2006525365A5 (enExample)
JP2005530811A5 (enExample)
JP2007506664A5 (enExample)
JP2010520214A5 (enExample)
JP2007502817A5 (enExample)
JP2005516898A5 (enExample)
JP2005517008A5 (enExample)
JP2004525178A5 (enExample)
EP1712548A3 (en) 5-amino-4-hydroxy-7-(pyridinylmethyl)-alkanamide derivatives and related compounds as renin inhibitors for the treatment of hypertension
JP2004510750A5 (enExample)
JP2005502636A5 (enExample)
JP2004523478A5 (enExample)
JP2008520662A5 (enExample)
JP2011508779A5 (enExample)
JP2010510263A5 (enExample)
JP2004538278A5 (enExample)
JP2006505567A5 (enExample)